Today: 28 April 2026
Browse Category

Stock Market 9 February 2026 - 10 February 2026

Spotify stock price dips after hours as SPOT earnings near — what investors watch Tuesday

Spotify stock price dips after hours as SPOT earnings near — what investors watch Tuesday

Spotify shares fell 1.8% to $414.84 in after-hours trading Monday ahead of its quarterly earnings report due Tuesday morning. Investors are watching for updates on subscriber growth, churn, and margins after recent price hikes. Spotify reported more than 713 million users and 281 million subscribers globally. The company raised its U.S. premium price to $12.99 last month.
CyberArk stock rises as Nasdaq flags Feb. 11 close for Palo Alto takeover

CyberArk stock rises as Nasdaq flags Feb. 11 close for Palo Alto takeover

CyberArk shares rose 4.4% to $409.22 after Nasdaq said its merger with Palo Alto Networks is expected to close before the market opens Feb. 11. Nasdaq plans to halt CyberArk trading after Tuesday’s after-hours session, with suspension effective Feb. 12 if the deal closes. The offer values CyberArk at about $410 per share based on Palo Alto’s latest price.
CoreWeave stock price jumps nearly 8% as CRWV rebounds; lawsuits and Feb. 26 earnings in focus

CoreWeave stock price jumps nearly 8% as CRWV rebounds; lawsuits and Feb. 26 earnings in focus

CoreWeave shares closed up 7.6% at $96.79 Monday, swinging between $87.39 and $97.86, and held steady after hours. The move followed a tech-led rally in U.S. stocks ahead of key payrolls and inflation data. Plaintiff law firms issued new notices about a securities class action, with a lead-plaintiff deadline set for March 13. CoreWeave will report earnings on Feb. 26.
Hims & Hers stock sinks after $49 Wegovy copycat U-turn and Novo Nordisk lawsuit

Hims & Hers stock sinks after $49 Wegovy copycat U-turn and Novo Nordisk lawsuit

Hims & Hers Health shares plunged 16% in after-hours trading Monday after the company pulled its $49 compounded semaglutide pill amid a patent lawsuit from Novo Nordisk. The stock touched $16.44 before recovering some losses. Novo seeks a court order to stop sales of unapproved compounded drugs. Leerink Partners cut its price target on Hims, citing uncertainty over future sales of compounded semaglutide.
Robinhood stock jumps after Wolfe upgrade as HOOD heads into earnings

Robinhood stock jumps after Wolfe upgrade as HOOD heads into earnings

Robinhood shares climbed 4.5% to $86.56 in after-hours trading Monday after Wolfe Research upgraded the stock and set a $125 price target. The move comes ahead of Robinhood’s fourth-quarter earnings release Tuesday, with investors watching for trends in trading and crypto revenue. Barclays warned that weak crypto sentiment and regulatory risks could weigh on results. Robinhood will hold its earnings call at 5 p.m. ET.
Palo Alto Networks (PANW) stock jumps as CyberArk merger close nears; traders eye Feb. 17 results

Palo Alto Networks (PANW) stock jumps as CyberArk merger close nears; traders eye Feb. 17 results

Palo Alto Networks shares rose 4.2% to $166 Monday, steady after hours, as Nasdaq said its $25 billion CyberArk merger is tentatively set to close before the Feb. 11 open. CyberArk shares are expected to be halted after trading Tuesday. Barclays cut its Palo Alto price target but kept an overweight rating. Morgan Stanley called Palo Alto its “favorite” cybersecurity stock for AI exposure.
Eli Lilly stock slides after-hours after $2.4 billion Orna deal — what to watch next for LLY

Eli Lilly stock slides after-hours after $2.4 billion Orna deal — what to watch next for LLY

Eli Lilly shares fell 1.3% to $1,044.67 in after-hours trading Monday after the company announced a deal to acquire Orna Therapeutics for up to $2.4 billion. The all-cash purchase includes milestone payments tied to clinical development. Investors are watching for updates on Orna’s cell therapy programs and regulatory decisions on Lilly’s obesity drug pipeline.
9 February 2026
Natural gas price dives as warm forecasts bite; Expand Energy stock slumps on CEO exit

Natural gas price dives as warm forecasts bite; Expand Energy stock slumps on CEO exit

U.S. natural gas futures dropped over 8% Monday to $3.141/mmBtu, hitting a three-week low as forecasts showed warmer weather likely to cut demand. Expand Energy shares fell 6.4% after CEO Domenic Dell’Osso’s exit and plans to relocate headquarters to Houston. EQT and Antero Resources also declined, while Cheniere Energy gained. Lower 48 gas output rose to 106.9 bcfd in February, with demand projected to fall sharply.

Stock Market Today

  • Gap Inc (GPS) Valuation Review Amid Recent Stock Pullback and Long-Term Recovery Potential
    April 27, 2026, 11:44 PM EDT. Gap Inc (GPS) shares are trading around $25.13, reflecting a 1-year total shareholder return of 20.42%, but showing a 6.23% decline over the past 90 days. Despite this short-term weakness, the stock remains undervalued with a value score of 6 and an intrinsic discount near 31%, while analyst price targets suggest roughly 22% upside to about $30.65. The bullish long-term recovery hinges on Gap's investments in digital tech, supply chain enhancements, and omni-channel retail strategies aimed at boosting efficiency and margins. Key risks include potential earnings pressure from Athleta's reset and trade tariff impacts. Investors should weigh these factors carefully before repositioning Gap in their portfolios.

Latest article

US Stock Market Today: S&P 500, Nasdaq Hit Records as After-Hours Trading Edges Higher

US Stock Market Today: S&P 500, Nasdaq Hit Records as After-Hours Trading Edges Higher

28 April 2026
The S&P 500 and Nasdaq closed at record highs Monday, while the Dow slipped 62.67 points to 49,168.04. After-hours, major U.S. indexes edged up less than 0.2%. Nvidia jumped 4% to a new high, topping $5 trillion in value, while Domino’s Pizza fell after forecasting weaker 2026 growth. Investors await Big Tech earnings and a Federal Reserve decision this week.
Go toTop